FORTE BIOSCIENCES INC (FBRX)

FBRX Stock Earnings: Forte Biosciences Reported Results for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Forte Biosciences (NASDAQ:FBRX) just reported results for the fourth quarter of...

FBRX Stock Earnings: Forte Biosciences Reported Results for Q4 2023

Forte Biosciences just reported results for the fourth quarter of 2023.

Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update

Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules

Forte Biosciences, Inc. Announces Third Quarter 2023 Results and Provides Business Update

Forte Biosciences rebuke board challengers, re-elect incumbents (NASDAQ:FBRX)

Despite calls or changes to its board, Forte Biosciences (FBRX) shareholders voted to keep the current slate of directors. Read more here.

ISS and Glass Lewis Recommend Forte Biosciences Stockholders Vote FOR Boardroom Change at the Company’s Upcoming Annual Meeting

Concerned Stockholders of Forte Biosciences and Its Independent Director Candidates Share Key Facts that Reinforce the Need for Urgent Change in the Company’s Boardroom

Concerned Stockholders of Forte Biosciences File Definitive Proxy Statement and Send Letter to Stockholders

Forte Biosciences, Inc. Announces Second Quarter 2023 Results and Provides Business Update

Forte Biosciences closes $25M financing, to advance FB-102 in 2024 (NASDAQ:FBRX)

Forte Biosciences (FBRX) said Tuesday it closed a $25 million financing to support the advancement of FB-102. The company said it plans to advance FB-102 into the clinic in 2024

Forte Biosciences, Inc. Announces $25 Million Financing and R&D Update for FB-102

Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules

Forte Biosciences, Inc. Announces First Quarter 2023 Results and Provides Business Update

Forte Biosciences, Inc. Announces Full Year 2022 Results and Provides Business Update

Mr. David Gryska Appointed to Forte Biosciences Board of Directors

Dr. Scott Brun, M.D. Appointed to Forte Biosciences Board of Directors

Forte Biosciences, Inc. Announces Third Quarter 2022 Results and Provides Business Update

Camac Partners Condemns Forte Biosciences’ Seemingly Defensive and Unjustifiable Capital Raise

Forte Biosciences, Inc. Announces Second Quarter 2022 Results and Provides Business Update

Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules

Forte Biosciences, Inc. Announces the Appointment of Dr. Hubert Chen, MD as Chief Scientific Officer and President

Forte Biosciences, Inc. Announces First Quarter 2022 Results and Provides Business Update

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Good morning! We've got another busy day ahead of us so let's get right into it with the biggest pre-market stock movers for Tuesday!